News
08.01.2020
Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate
07.01.2020
HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry
07.01.2020
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers
20.12.2019
WWTF fördert Forschungsprojekte der MedUni Wien im aktuellen Life Science Call Imaging